Source: European Competition Law Review. Unidade: IRI
Subjects: INDÚSTRIA FARMACÊUTICA, PREÇOS, CONCORRÊNCIA, UNIÃO EUROPEIA, DINAMARCA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TANG, Yi Shin. Excessive pricing in the pharmaceutical sector: recent impacts of the “CD Pharma” case in Denmark. European Competition Law Review, v. 42, n. 2, p. 91-96, 2020Tradução . . Disponível em: https://www.sweetandmaxwell.co.uk/Catalogue/ProductDetails.aspx?productid=7051&recordid=455. Acesso em: 06 nov. 2024.APA
Tang, Y. S. (2020). Excessive pricing in the pharmaceutical sector: recent impacts of the “CD Pharma” case in Denmark. European Competition Law Review, 42( 2), 91-96. Recuperado de https://www.sweetandmaxwell.co.uk/Catalogue/ProductDetails.aspx?productid=7051&recordid=455NLM
Tang YS. Excessive pricing in the pharmaceutical sector: recent impacts of the “CD Pharma” case in Denmark [Internet]. European Competition Law Review. 2020 ; 42( 2): 91-96.[citado 2024 nov. 06 ] Available from: https://www.sweetandmaxwell.co.uk/Catalogue/ProductDetails.aspx?productid=7051&recordid=455Vancouver
Tang YS. Excessive pricing in the pharmaceutical sector: recent impacts of the “CD Pharma” case in Denmark [Internet]. European Competition Law Review. 2020 ; 42( 2): 91-96.[citado 2024 nov. 06 ] Available from: https://www.sweetandmaxwell.co.uk/Catalogue/ProductDetails.aspx?productid=7051&recordid=455
